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ABSTRACT Fusion is a crucial event in the infection of animal cells by enveloped viruses (e.g., HIV or influenza). Viral fusion
is mediated by glycoproteins, spanning the viral envelope, which attach to a membrane surface and induce fusion of the viral
envelope to the cellular membrane. Influenza fusion protein (hemagglutinin) contains an amino-terminal segment critical to
fusion, referred to as the fusion peptide. We show here that the native fusion peptide (wt-20) of hemagglutinin destabilizes
membranes formed of 99% 1 -stearoyl-2-oleoylphosphatidylcholine (SOPC). The first step in destabilization is rapid insertion
of the peptide into the membrane, in which membrane area increases by as much as 11% in just seconds. We visualized and
quantified the area expansion by using optical video microscopy combined with micropipette aspiration. This rapid mem-
brane area expansion is followed by the formation of membrane defects in the size range of 0.5 nm, and results in membrane
rupture. Both the rate of area increase and maximum area increase are significantly higher at a pH near 5.0 compared to pH
7.0. These results suggest that enhanced membrane insertion of wt-20 and accompanying area expansion at pH 5.0 are
responsible for the relatively greater lytic activity at this pH. We show that a deletion of the N-terminal glycine of wt-20 results
in a lack of area expansion or membrane perturbation at pH 5.0.
INTRODUCTION
Membrane fusion is a critical event in the infection of all
animal cells by enveloped viruses. Viral fusion is the pro-
cess by which the lipid-containing membrane of the virus
(envelope) and the cellular membrane become continuous,
resulting in the mixing of cellular and viral aqueous com-
partments (White, 1992). Enveloped virus fusion reactions
fall into two categories, low pH-dependent and pH-indepen-
dent. Viruses with pH-dependent activity (e.g. influenza)
undergo receptor-mediated endocytosis and fuse with the
endosomal membrane in the low pH endosomal environ-
ment (Helenius et al., 1980; Matlin et al., 1981). pH-inde-
pendent viruses (e.g., HIV) fuse mainly with the plasma
membrane, but may fuse with the endosome as well (White,
1990; Grewe et al., 1990; Sinangil et al., 1988; McClure et
al., 1988).
Enveloped viruses employ specific glycoproteins (viral
fusion proteins) spanning the viral envelope to mediate
attachment to a membrane surface and to induce fusion. For
fusion to occur, these glycoproteins bridge the gap between
the envelope and the cellular membrane and cause disrup-
tion and reorganization of the envelope and cellular mem-
brane, leading to fusion. A striking feature of most viral
fusion proteins is the presence of a fusion peptide. A large
number of fusion peptides that have been identified are
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found on the amino-terminal end of the fusion protein,
external to the viral envelope (Hoekstra, 1990). It has been
demonstrated that the fusion peptide becomes embedded in
the neighboring cellular membrane before fusion (Stegmann
et al., 1991; Harter et al., 1989; Weber et al., 1994). How-
ever, very little is known of the mechanism of disruption
and reorganization of the target membrane, or the dynamics
of these processes.
The fusion peptides of both pH-dependent and pH-inde-
pendent viruses contain a large number of apolar amino acid
residues. Fusion peptides show a tendency to form "sided
helices," with most of the bulkier, more hydrophobic resi-
dues found on one hemiface of the helix, and most of the
smaller apolar amino acids (e.g., alanine and glycine) resid-
ing on the other side of the helix (White, 1990). Although
the relevance of this helical formation to membrane fusion
has been argued (Gallaher et al., 1992; Gray et al., 1996),
the apparent role of segregation of hydrophobic residues is
to interact with the hydrophobic chains of the membrane
lipids during and before fusion.
Many viral fusion peptides have been synthesized (Stein-
hauer et al., 1995; Wharton et al., 1988; Duzgune§ and
Shavnin, 1992; Duzgune§ and Gambale, 1988; Burger et al.,
1991; Lear and DeGrado, 1987; Rafalski et al., 1991;
Ishiguro et al., 1993; Slepushkin et al., 1990; Mobley et al.,
1995; Glushakova et al., 1992; Wagner et al., 1992). The
activity of the fusion peptide is often measured by its ability
to fuse and/or lyse (cause leakage) of vesicles or red blood
cell membranes (hemolysis) (Wharton et al., 1988; Wagner
et al., 1992; Mobley et al., 1995; Duzgune§ and Shavnin,
1992; Lear and DeGrado, 1987; Rafalski et al., 1991). In
these studies, fusion is generally accompanied by lysis
and/or leakage of contents; thus the actual ability of fusion
peptides alone to cause fusion has been argued. Nonethe-
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less, the lytic activity of fusion peptides correlates well with
their in vivo fusion activity. For example, the lytic activity
of wild-type peptides of influenza virus increases greatly as
the pH decreases to -5 (endosomal pH) (Wharton et al.,
1988; Rafalski et al., 1991; Wagner et al., 1992; Diizguneq
and Shavnin, 1992). Furthermore, mutant peptides corre-
sponding to viruses with no or reduced fusion activity do
not enhance the release of solutes from vesicles (Duzgiine,
and Gambale, 1988).
The pH-dependent lytic activity of certain fusion peptides
makes them ideal for use in gene transfer systems (Ander-
son, 1995; Morsy et al., 1993) for rupture of the endosomal
membrane. These gene transfer systems are much simpler,
and potentially more compact, than virus-based systems that
use reproductive deficient adeno- or retroviruses. Peptide-
based gene transfer systems involve the formation of aggre-
gates, containing DNA, fusion peptide, and positively
charged polymer, or lipid held together by electrostatic
interactions. These aggregates are internalized by endocy-
tosis. Fusogenic peptides of influenza virus have been used
successfully for rupture of the endosomal membrane, result-
ing in release of DNA into the cell cytoplasm (Curiel et al.,
1991; Plank et al., 1994; Wagner et al., 1992).
Using micropipette aspiration, we have concentrated our
efforts on measuring the interaction of fusion peptides of the
well-studied influenza hemagglutinin (HA) fusion protein
(from the X31 strain) with unilamellar vesicles (Soltesz and
Hammer, 1995). The fusion peptide region of HA was
initially identified by demonstrating that deletions in the
fusion peptide region of the complete fusion protein resulted
in diminished viral fusion (Daniels et al., 1985; Gething et
al., 1986). The 20-amino acid fusion peptide from X31
(Wharton et al., 1988), referred to as wt-20, contains three
negatively charged residues that are partially neutralized at
a pH of 5, corresponding to the pH of the endosome. wt-20
becomes more a-helical at a pH of 5, in comparison to a pH
of 7, when in the presence of phosphatidylcholine mem-
branes (Wharton et al., 1988). This peptide is reported to
lyse red blood cells at a pH of 5 and 7, with approximately
four times greater lytic activity at pH 5 (Wharton et al.,
1988). Furthermore, wt-20 shows diminished fusion activity
as the pH is raised from 5 to 7 (Wharton et al., 1988).
Viral membrane fusion and membrane disruption caused
by fusion peptides are dynamic processes, occurring on time
scales of minutes and seconds (Stegmann et al., 1991;
Hoekstra et al., 1985; Zimmerberg et al., 1994; Hug and
Sleight, 1994; Lear and DeGrado, 1987; Ishiguro et al.,
1993; Slepushkin et al., 1990; Glushakova et al., 1992;
Struck et al., 1981; Fonteijn et al., 1992; Bagai et al., 1993;
Melikyan et al., 1993; Wharton et al., 1988; Diizgune, and
Shavnin, 1992; Rafalski et al., 1991; Mobley et al., 1995).
Although circular dichroism, Fourier transform infrared
spectroscopy, tryptophan fluorescence, and spin labeling
(for examples see Wharton et al., 1988; Clague et al., 1991;
Lear and DeGrado, 1987; Rafalski et al., 1991; Gray et al.,
1996) have been used to obtain information regarding bulk
occur as a result of association with membrane bilayers,
there is little information on the dynamics of peptide inser-
tion into the membrane. Furthermore, there is little infor-
mation on the resulting restructuring of the membrane or the
formation and evolution of membrane defects.
We focus here on the use of micropipette aspiration to
detect the insertion of a fusion-active peptide (wt-20) and a
fusion-defective peptide (AG1) of HA into lipid membranes
and monitor the resulting membrane instabilities. With mi-
cropipette aspiration, we can directly expose a single-mem-
braned vesicle to a peptide-containing solution at a con-
trolled membrane tension. Exposure can proceed under
various solution conditions critical to fusion. Uptake of
inserting species in the membrane can be detected by ex-
pansion of the vesicle surface area, and the formation of
porous defects (Zhelev and Needham, 1993; Needham and
Zhelev, 1995) can be detected directly. Micropipette aspi-
ration uses vesicles that are sufficiently large (-25 ,um in
diameter) that changes in the projected area, aspirated into
a micropipette, can be monitored by an optical microscope
(Needham and Zhelev, 1995; Simon et al., 1994). Exposure
of the vesicle to fusion peptide results in an easily detectable
increase in the projected area, giving directly the change in
membrane surface area due to the incorporation of fusion
peptide. The formation of porous defects of a size slightly
larger than that of glucose (solute outside of vesicle, diam-
eter 0.5 nm; Needham and Zhelev, 1995) results in the
diffusion of glucose into the vesicle and the cotransport of
water. This transport causes vesicle swelling, leading to an
observable decrease in the length of the projection in the
pipette. In addition, changes in mechanical properties and
the tensile strength of a vesicle due to peptide insertion can
be measured.
MATERIALS AND METHODS
Materials
l-Stearoyl-2-oleoylphosphatidylcholine (SOPC) and l-palmitoyl-2-
oleoylphosphatidylserine (POPS) were purchased from Avanti Polar Lipids
(Alabaster, AL) and were used without further purification. Chloroform
and methanol used to form lipid films for vesicle production were from
Fisher (Fairlawn, NJ) and were high-performance liquid chromatography
(HPLC) grade. All solutes used were from Sigma (St. Louis, MO) and were
ultra grade. Water was obtained from a Milli-Q UV Plus system (Millipore,
Bedford, MA).
The two peptides synthesized were based on the HA fusion-active
(wt-20) and fusion-defective (AGI) peptides previously synthesized by
Wharton et al. (1988):
wt-20 GLFGAIAGFIENGWEGMIDG
AG1 LFGAIAGFIENGWEGMIDG
Peptides were stored frozen in dimethyl sulfoxide (DMSO) (Fisher, HPLC
grade) at 1 mM concentration. Peptides were mixed with buffer solution
immediately before use.
The wt-20 peptide was synthesized for us by Star Biochemicals (Tor-
rance, CA). The molecular mass of the peptide was confirmed for us by
Multiple Peptide Synthesis (San Diego, CA).
The AGI peptide was synthesized on a 0.25 mmol scale with an ABI
structural or orientational changes of fusion peptides that
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1991). Peptide synthesis reagents, including solvents and Fmoc amino acid
derivatives, were from Perkin-Elmer Applied Biosystems (Foster City,
CA). A prederivatized Wang p-benzyloxybenzyl alcohol resin (Applied
Biosystems) with the C-terminal glycine was used for the stepwise syn-
thesis of the peptide. All residues were double-coupled to optimize the
yield of the fusion peptide sequence. After cleavage of the peptide from the
resin, the crude product was purified by reverse-phase HPLC employing a
Vydac C4-column (Vydac, Hesperia, CA). The material was chromato-
graphed by using a 60-min linear gradient, with a starting phase of water
and an eluting phase of 100% acetonitrile containing 0.1% trifluoroacetic
acid as an ion-pairing agent. After concentration of the peptide by vacuum
centrifugation, the peptides were freeze-dried from acetonitrile: 10 mM HCI
(1: 1, v:v) to remove any counterions from the chromatography solvent. The
molecular mass of the peptide was then confirmed by fast atom bombard-
ment mass spectroscopy (Center for Molecular and Medical Sciences Mass
Spectrometry, University of California, Los Angeles, CA).
Preparation of vesicles
Vesicles containing 100 mM sucrose were formed of 99% SOPC and 1%
POPS by modification of an electric field technique developed by Ange-
lova et al., 1992. We included 1% POPS to prevent vesicle aggregation and
adhesion to chamber surfaces. Briefly, 50 ,ul of a chloroform:methanol
(2:1) solution containing 0.5 mg/ml of lipid (99% SOPC, 1% POPS) was
applied to two electrodes formed of 1-mm-diameter platinum wire (Al-
drich, Milwaukee, WI). A 100-,ul syringe was used to spread this solution
on the electrodes. After drying under mild vacuum for 2 h, the electrodes,
placed 3 mm apart, were sealed in a chamber (volume of -1.5 ml). The
chamber was filled by syringe with 100 mM sucrose solution. A 3-V,
10-Hz sine wave was applied for half an hour across the two wires with a
signal generator (BK Precision, Chicago, IL). Subsequently, the frequency
was lowered to 3 Hz for 15 min, 1 Hz for 7 min, and 0.5 Hz for 7 min. The
vesicles were harvested by flowing an additional 1.5 ml of sucrose solution
through the chamber. This technique yields mainly unilamellar large ves-
icles, with a large percentage between 20 ,um and 30 ,um useful for
micropipette aspiration. Vesicles were no longer used 3 days after production.
Micropipette aspiration chamber
The chamber used in these experiments (Fig. 1) contained two sections
separated by a 1/32-inch-thick teflon sheet. A 0.9-mm hole was bored
I
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FIGURE 1 Schematic of micropipette aspiration chamber used in these
experiments. The chamber is made by sandwiching a teflon spacer (1), four
plexiglass spacers (these define the chamber size, one is visible here) (2),
and two coverslips (3,4) between two aluminum plates (5,6) held together
by screws (screw hole shown here) (12). The teflon spacer divides the
chamber into two sections. One section (7) is -200 ,ul in volume and
contains a buffer solution with vesicles. The other section (8) is --150 ,u1
in volume and contains the buffer solution with fusion peptide. Evaporation
is minimized by delivering saturated nitrogen to the air-solution interfaces
(13,14). When a vesicle, held by the micropipette (15), is transferred from
section 7 to section 8, the capillary tubing (9) remains stationary, and the
entire chamber is moved from left to right by using the microscope stage.
As a result, a single vesicle (10) is transferred through the 0.9-mm hole
(11) and exposed to peptide solution in section 8. Only one vesicle is
transferred per experiment.
through the separator to allow transfer of vesicles from one section to
another via micropipette. The hole remained blocked via capillary tubing
until the vesicle was transferred from one side to the other. Water-saturated
nitrogen was delivered to the air-solution interface of both sections to
minimize evaporation.
Production and calibration of micropipettes
Capillary glass (Friedrich and Dimmock, Millville, NJ) was heated and
elongated with a David Kopf Instruments (Tujunga, CA) micropipette
puller. The glass was approximately broken at an inner diameter of 8 p.m.
Subsequently, a clean break was obtained with a microforge (Technical
Products International, St. Louis, MO) (Needham, 1993). Micropipettes
were then coated with a nonsticking agent, Surfasil (Pierce, Rockford, IL),
from a 1% solution in chloroform. Pipettes used were between 7.0 p.m and
9.0 p.m in inner diameter.
Precise measurement of the inner diameter of each pipette was accom-
plished during the production of pipettes. Briefly, glass needles were drawn
on the pipette puller, coated with gold, and imaged by scanning electron
microscopy. Image analysis was used to obtain the length versus width
profiles of the needle tips. Each profile was fitted with a fifth-order
polynomial. When each pipette was produced, a glass needle was gently
inserted as far as possible down the bore of the pipette. The fifth-order
polynomial was used to obtain the width of the pipette from the length of
insertion.
Micropipette aspiration
One half-hour before aspiration began, the 200-,ul section of the chamber
(see Fig. 1) was filled with a solution containing 100 mM glucose, 1 mM
Na citrate, 1 mM HEPES, 1 mM 2-(N-morpholino)ethanesulfonic acid, and
0.03 weight% bovine serum albumin (fraction V, low heavy metals;
Calbiochem-Novabiochem, La Jolla, CA), pH adjusted with 1 N and 0.1 N
NaOH or HCI solutions. The 150-,ul section was filled with the same
solution containing peptide (which had been dispersed from a 1 mM
solution in DMSO with vortexing). The maximum concentration ofDMSO
was 2% for a 20 ,uM peptide solution. Pretreating the chamber for one
half-hour with the albumin present in the test solutions results in the
dissipation of charges on the glass microscope slides used in the chamber
(Needham, 1993). Therefore, the albumin is thought to bind strongly to the
glass in the chamber. After one half-hour, -6 p.l of vesicle solution was
transferred to the 200-,ul chamber.
Aspiration of vesicles was performed by the use of a two-chambered
manometer with attached Validyne (Northridge, CA) pressure transducers
and monitor. Initially, a test vesicle was aspirated by micropipette suction
to determine the area compressibility (K) and lysis tension (TIyse) (for good
references on material properties measurements by micropipette aspiration,
see Evans and Needham, 1987, and Evans and Rawicz, 1990). This
procedure was followed to confirm that the vesicles had the same basic
properties at the start of the experiments and to obtain a mean K and TIYse
for normal vesicles. Area compressibility data were obtained by increasing
the suction pressure on the vesicle in a stepwise manner (-4 cm water per
step) until the vesicle lysed. From the suction pressure changes (AP), we
calculated the isotropic tension T (T = APRP/2{ 1-R/RP}), where Rp and
Ro are the pipette and exterior segment radii, respectively. From the
accompanying changes in the projection length (AL), we calculated the
areal strain, a (a can be closely approximated by 112{(RW/R0)2 - (Rp/
RO)3}AL/Rp; Evans and Rawicz, 1990). The area compressibility modulus,
K, was determined by the slope of the isotropic tension, T, versus areal
strain, a. Tjyse was determined as the tension of vesicle lysis.
Immediately after the compressibility and lysis tension test, a vesicle
was chosen for the insertion experiment. The vesicle was prestressed to -4
dyn/cm to ensure that the vesicle membrane was completely flattened.
Subsequently, the aspiration pressure was lowered and maintained through-
out the rest of the experiments to give a constant membrane tension
between 0.1 and 0.2 dyn/cm. The vesicle was positioned -150 plm from
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the capillary tubing blocking the hole connecting the two sections of the
chamber. The entire chamber was moved by using the microscope stage,
yielding the removal of the capillary tubing from the hole and the transfer
of the vesicle from the 200-,ul chamber section to the 150-,ul section
containing the peptide. Insertion was monitored by measuring the change
in projection of the vesicle in the pipette as the vesicle membrane area
increased.
Area expansion, area compressibility, and lysis tension data were re-
corded with a Nikon inverted diaphot-TMD microscope equipped with
Hoffman optics (Modulation Optics, Greenvale, NY), a Videoscope CCD-
200 video camera (Washington, DC), a video encoder (suction pressure
and time are encoded frame by frame on all images; courtesy of R. Waugh,
University of Rochester, NY), and a SONY SVO-9500 VCR. Image
analysis software and hardware (Inovisions Corporation, Durham, NC)
were used to obtain vesicle dimensions, projection versus time data, and
the images shown here.
RESULTS
pH-dependent insertion of wt-20
To measure the insertion of wt-20 into SOPC:POPS (99:1)
vesicle bilayers at various pHs, single vesicles were trans-
ferred from a solution (containing no peptide) at the test pH
to the chamber section containing 10 ,uM peptide (at the
same pH). When we exposed a vesicle at pH 5.0 to a
solution containing 10 ,uM wt-20, the projection increased
because of membrane insertion of wt-20 (Figs. 2 A-C and 3
A). Typically, the projection increased by - 15 ,um for an
8-,um pipette. Subsequently, the vesicle swelled, because of
the cotransport of water and the relatively smaller sugar
species, glucose, through porous defects in the membrane
(Needham and Zhelev, 1995). Swelling caused the vesicle
projection in the pipette to decrease (Figs. 2 D-E and 3 A).
Eventually, the vesicle membrane bilayer area stretched
beyond a critical area expansion, which lead to failure
(lysis) of the vesicle membrane. When lysis occurred, the
vesicle was slowly aspirated into the pipette bore (Fig. 2 F).
Increases in projection (AL) (Figs. 2 and 3 A) were con-
verted into membrane area changes, normalized by the
initial area of the vesicle (AA/AO), plotted versus time,
allowing the comparison of measurements taken from ves-
FIGURE 2 Sequential videomicrographs of a large unilamellar vesicle held under constant, low membrane tension (0.15 dyn/cm) exposed to 10 JIM
wt-20 at pH 5.0. (A) At the moment of exposure. (B,C) Increase in vesicle projection length (AL) resulting from the adsorption and intercalation of wt-20.
(D,E) The formation of porous defects and the permeation of glucose and water into the vesicle has caused the vesicle to swell, resulting in a decreased
projection length. (F) The vesicle lyses and is aspirated into the pipette bore because of the mild suction in the pipette.
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icles and pipettes of various sizes AA = 27rRp(1 - RI
RO)AL (Evans and Needham, 1987). Swelling of the vesicle
was monitored by the magnitude of the decrease in the
projection length. These measurements were converted into
volume changes normalized by the volume of the vesicle at
the onset of swelling (AWVIV). The calculation of AVIV0 is
based on the volume change indicated by the decrease in
projection length. The total change in volume was found to
be consistent with measurements taken of the vesicle vol-
ume outside of the pipette before rupture.
The area expansion profiles (AA/AO versus time) of ves-
icles exposed to 10 ,uM wt-20 at pH 5 through 7.0 show the
dramatic effect of pH on the vesicle area expansion result-
ing from the insertion of this peptide (Fig. 3 B). The initial
rate of area expansion, the time at which the membrane
became porous, and maximum area expansion were pH
dependent (Table 1 and Fig. 3, B and C). Table 1 reports
results for all runs performed. For each run at pH 6 and 7,
a relatively small amount of area expansion was followed
by a plateau. The presence of the plateau, with an almost
undetectable change in area with time, may indicate that the
membrane was nearing the equilibrium membrane concen-
tration of wt-20. The plateau was followed by a decrease in
the vesicle projection length, resulting from the permeation
of the vesicle to glucose and water, and eventual lysis.
Significant qualitative differences are shown in the area
expansion plots when vesicles were exposed to wt-20 at a
pH of 5.0. At a pH of 5.0, wt-20 adsorption resulted in an
average maximum area fraction change, AA/Aomax, of
-0.09 (compared to AA/Ao,max of -0.04 at a pH of 6.0). At
a pH of 6.0, the permeation start times recorded were -6
and 7 min. In comparison, the average permeation start time
at pH 5.0 was -80 s. A closer look at the area expansion
plots (Fig. 3 C) and data (Table 1) of vesicles exposed to
wt-20 at pH 4.5, 5.0, and 5.5 shows that significant in-
creases in area expansion began at pH 5.0 (corresponding
roughly to the endosomal pH).
To demonstrate that the area expansion and lysis tension
observed were not simply due to the small amount of
DMSO used to solubilize the peptides, we transferred ves-
icles to pH 5.0 and pH 7.0 solutions containing 1% DMSO,
corresponding to the amount used in these experiments. We
found that transfer of vesicles to 1% DMSO in buffer
solution resulted in small increases in projection length
relative to vesicles in wt-20 at pH 5.0. This baseline change
in projection was due to a difference in osmotic strength
between the two sections of the chamber and some evapo-
ration that occurs during the experiment. Transferring a
vesicle to this slightly hypertonic solution caused the vesicle
volume to shrink, thus balancing the osmotic strength inside
and outside of the vesicle. The projection length increased
slightly to accommodate the decrease in volume. The vol-
ume decrease, normalized by the initial volume of the
vesicle (AWVIV) versus time, is shown in Fig. 3 B. This
change in osmotic strength was present in all experiments
shown here; this apparent contribution to AA/AO versus time
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FIGURE 3 (A) Raw projection versus time data for exposure of vesicle
to 10 ,.tM wt-20 at pH 5.0. (B,C) Fractional area changes (AA/A., axis on
left) and fractional volume changes (AVIV0, axis on right) versus time for
vesicles exposed to 10 ,uM wt-20: *, pH 7.0; *, pH 6.0; A, pH 5.5; *, pH
5.0; 0, pH 4.5; 0, 1% DMSO, pH 7.0. , AA/A.; -- -, AVIV0. Area
expansion due to uptake of wt-20 occurred to a greater extent at pH 5
compared to pH 7. When vesicles are exposed to the buffer solution
containing the same concentration of DMSO used to solubilize the peptide,
the vesicle volume decreases slightly because of a small increase in
external osmotic strength. Therefore a baseline AA/A. in all experiments
can be estimated by the apparent area expansion (an example run is shown
here; 0).
is shown in Fig. 3 B. Thus the values of AA/Ao,max for all
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TABLE I Data for exposure of vesicles to
hemagglutin peptides
Permeation AA/Ao, max*
Concentration start time (maximum AA/A.
pH (AM) (min:s) increase)
wt-20
4.5 10 0:15 0.116
4.5 10 0:14 0.130
5.0 10 0:41 0.114
5.0 10 1:45 0.0886
5.0 10 1:25 0.0947
5.0 10 0:30 0.123
5.0 10 0:50 0.0521
5.0 10 3:15 0.0873
5.5 10 1:46 0.0396
6.0 10 7:08 0.0385
6.0 10 6:05 0.0290
7.0 10 10:12 0.0181
7.0 10 6:05 0.0255
4.5 20 0:09 0.122
4.5 5 3:20 0.114
4.5 5 1:31 0.100
4.5 5 1:16 0.0893
4.5 2.5 6:30 0.0476
4.5 1 0.0140
4.5 1 0.0170
AGI
5.0 10 0.00678
5.0 10 0.00342
5.0 10 - 0.0117
7.0 10 0.00893
DMSO (controls)"
pH 7.0 0.00653
pH 7.0 0.0172
pH 5.0 0.00624
pH 5.0 0.00298
Time for permeation to start after exposure to peptide and maximum
fractional area increases.
*Maximum area increase (at plateau if present) divided by initial area
before peptide exposure.
#No peptide, 1% DMSO.
measurements should be compared to DMSO control values
(Table 1).
We compared the area compressibility (K) and lysis ten-
sion (TIyse) of vesicles exposed to DMSO with vesicles that
were not exposed to DMSO and found them to be compa-
rable. The mean K of vesicles that were not exposed to
DMSO (vesicles in glucose buffer, pH 4.5-7.0) was found
to be 166 dyn/cm (SD 14 dyn/cm, with all vesicles within
1.75 times the SD of the mean). The mean Tlyse of vesicles
(no DMSO) was found to be 7.0 dyn/cm (SD = 1.6 dynlcm,
with all vesicles within 1.75 times the SD of the mean). The
K of pH 5.0 and pH 7.0 vesicles exposed to 1% DMSO was
170 dyn/cm and 154 dyn/cm, respectively. Values of Tlyse
for pH 5.0 and pH 7.0 vesicles exposed to 1% DMSO were
9.0 dyn/cm and 8.67 dyn/cm, respectively.
Inactive AG1 mutant insertion
To determine if differences in area expansion could distin-
guish an active fusion peptide from an inactive peptide, we
monitored the area expansion of vesicles exposed to a
peptide with decreased fusion and negligible hemolytic
activity in comparison to wt-20 (Wharton et al., 1988). This
fusion-defective peptide, referred to as AGI (see Wharton et
al. 1988), has an amino acid sequence identical to that of
wt-20, but the N-terminal glycine is absent. We found (Fig.
4) that at both pH 5.0 and pH 7.0, exposure of vesicles to a
10 ,uM solution of AGI resulted in a AA/A. change similar
to control experiments containing DMSO alone (see expla-
nation above). The lysis tension of these vesicles was tested
after - 15 min and was found to be comparable (5.97
dyn/cm at pH 5.0 and 7.22 at pH 7.0) to the lysis tension of
control vesicles (reported above).
Effect of pH change on insertion
To mimic the low pH environment encountered by influ-
enza virus in the endosome, we transferred a vesicle from a
solution containing a small amount (2.5 ,uM) of wt-20 at a
pH of 7.00 to another solution containing the same amount
of wt-20 at pH 5.0 (Fig. 5). This procedure allowed us to
trigger the area expansion of the vesicle, resulting from the
pH-dependent change in conformation of wt-20 (Fig. 5).
Retransfer to the pH 7.0 solution resulted in complete re-
covery of the original vesicle size, presumably because of
desorption of wt-20. After desorption, the lysis tension was
tested and was found to be within normal range at 5.77
dyn/cm. In a separate control experiment (data not shown),
vesicles transferred to a pH 7.0 solution containing 2.5 ,uM
wt-20 do not exhibit area expansion from the insertion of
wt-20 over the time scales of this experiment. Furthermore,
0.02
0.015
AA/AO
0.01
0.005
0
0:00 4:00 8:00 12:00 16:00
time (min:sec)
FIGURE 4 AA/A. versus time for vesicles exposed to 10 ,tM of a
nonhemolytic, fusion-defective mutant of wt-20 lacking the N-terminal
glycine: *, pH 5.0; *, pH 7.0. These plots are very similar to the DMSO
plots in Fig. 2 B, in which no peptide was present. Repeated here is a plot
for the apparent area expansion of a vesicle exposed to 1% DMSO at a pH
of 5.0 (0), corresponding to the amount of DMSO used in these experi-
ments. The apparent increase in AA/AO is simply due to a slight difference
in osmotic strength between the two chambers and a small amount of
evaporation that occurs over long time scales, which leads to an increase in
the vesicle projection.
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0.03
0.02
AA/AO
0.01
0
-0.01
4:00 0:00 4:00 8:00 12:00 16:00
time (min:sec)
FIGURE 5 Effect of pH change for a vesicle exposed to wt-20 (U).
Vesicle exposed to 2.5 ,uM wt-20, pH 7.0, was transferred to a 2.5 ,uM
wt-20 solution at pH 5.0. Transfer resulted in an increase in AA/A. due to
the insertion of wt-20 into the lipid bilayer. Placing the vesicle in a pH 7.0
solution results in complete recovery of the original surface area and
normal mechanical properties. As a control, the experiment was repeated
without wt-20 (0) to obtain the apparent change in AA/A. resulting from
osmotic strength differences between the two chamber sections.
the lysis tension was within normal range, 7.48 dyn/cm,
after 15 min of exposure.
Effect of concentration change on insertion
Reversibility of wt-20 peptide uptake was tested by trans-
ferring a vesicle with inserted wt-20 in a pH 5.0, 5 ,AM,
wt-20 solution to a solution free of the peptide at a pH of 5.0
0.05
0.04
0.03
AA/AO
0.02
0.01
0
-0.01
0:00 4:00 8:00 12:00 16:00
time (min:sec)
(Fig. 6). This transfer resulted in partial recovery of the
initial area of the vesicle. One-half of the area expansion
remained, presumably from membrane-bound peptide. A
lysis tension test found the vesicle to be weakened (2.3
dyn/cm) in comparison with the range of lysis tensions for
control vesicles reported above. However, the area com-
pressibility of the vesicle (167 dyn/cm) was within normal
range, indicating that a decrease in area compressibility was
not responsible for the lowered lysis tension. Therefore,
defects formed in the vesicle membrane were most likely
responsible for the lowered lysis tension.
Effect of concentration on insertion
To determine the effect of bulk concentration on the ad-
sorption of wt-20, we exposed vesicles to wt-20 at several
concentrations (Table 1 and Fig. 7). Exposure of a vesicle to
1 ,uM wt-20 at pH 4.5 resulted in an increase in projection
length indistinguishable from controls containing DMSO at
pH 5.0 (Figs. 4 and 7). Exposure to 5 ,uM wt-20 resulted in
an average AA/AO max of -0.10. For the plot shown (Fig. 7,
5 ,uM wt-20), we observed a slower rate of change of AA/AO
followed by a more rapid AA/A. change with time and the
formation of defects. We saw similar changes in {AA/AA}/t
when a vesicle became permeable to glucose early in the
adsorption (data not shown). Apparently, the porous defects
in the membrane can seal, leading to an increased area
expansion rate. At 20 ,uM wt-20, the entire area expansion
and volume expansion cycle occurs in a matter of 20 s. The
AA/Aoma obtained before permeation was -0.12.
DISCUSSION
A major finding of this work is the rapid area expansion of
the lipid membrane of vesicles (99% SOPC) exposed to
bulk fusion peptide concentrations near 10 ,uM. The ob-
served extent of area expansion and subsequent permeation
0.15
0.1
AA/AO
20:00
FIGURE 6 Exposure of a vesicle to a 5 ,uM wt-20 solution at a pH of 5.0
(U) and transfer to a solution at the same pH containing no wt-20 resulted
in nearly complete desorption of wt-20. After partial desorption, the vesicle
has a lowered lysis tension (2.6 dyn/cm in comparison to a mean lysis
tension of 7.0 for test vesicles), probably as a result of perturbation of the
membrane bilayer by the presence of wt-20 in the bilayer. As a control, the
experiment was repeated without wt-20 (0) to obtain the apparent change
in £4/AO resulting from osmotic strength differences between the two
chambers.
0.05
0:00 2:00 4:00 6:00 8:00 10:00
time (min:sec)
0.3
0.2
AV/VO
0.1
0
FIGURE 7 , £A/AO versus time; and -- -, AV/V. versus time for
vesicles exposed to different concentrations of wt-20 at a pH of 4.5: *, 1
,uM; *, 5 ,uM; *, 20 ,uM.
pH7.0 pH5.0 pH7.0
...............I.....................
lysis tension
2.6 dyn/cm
exposed to removed from wt-20
5iM wt-20
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to glucose are pH dependent. The pH dependence of the
extent and rate of area expansion and vesicle permeation
corresponds closely to increases in fusogenic and hemolytic
activity of this peptide when the pH is lowered to -5
(Wharton et al., 1988). These observations suggest that the
ability of a peptide to induce area expansion (through in-
sertion) is an important determinant of fusogenic and lytic
activity. Our results show that the native hemagglutinin
fusion peptide (wt-20) from the X31 strain of influenza
virus is taken up rapidly into SOPC:POPS (99:1) mem-
branes, resulting in large increases in membrane surface
area (as much as 11% of the original area). In a pH range
from 4.5 to 7.0, exposure to 10 ,M wt-20 resulted in the
permeation of the vesicles to glucose (diameter 0.5 nm),
leading to vesicle swelling and rupture. Exposure of vesicles
to wt-20 at pH 5 resulted in approximately three times
greater AA/Ao,max in comparison to pH 7 at the same bulk
concentration. In general, the extent of area expansion ap-
pears to be closely related to the time required for the
membrane to become porous (Table 1).
Insertion of the wt-20 peptide can be triggered simply by
lowering the pH from neutral pH to pH 5.0. wt-20 peptide
insertion is mainly reversible at pH 5.0 and can be com-
pletely reversed if the pH is returned to neutrality at micro-
molar concentrations. In contrast, Morris et al. (1989) ob-
served that when fusion was mediated by the entire
hemagglutinin protein, the process could only be reversed
by raising the pH in the first 2-10 s. However, fusion
involves major rearrangements of the lipid bilayer structure
that are probably not involved here.
An estimate of the number of wt-20 peptides inserted into
the membrane can be obtained by using the volume occu-
pied by each residue (Gallaher et al., 1992). Assuming that
the wt-20 peptide is inserted transmembrane, with a bilayer
thickness of 40 A (Marsh, 1990), the peptide will occupy an
area of -30 A2 (this estimate is probably a lower bound on
the surface area; Burger et al., 1991, report that the mini-
mum "monolayer" surface area is 290 A2 per HA fusion
peptide). For a value AA/AO of -0.1, there will be -6 X 108
wt-20 peptides inserted in the bilayer. This is in comparison
to -6 X 109 SOPC molecules in the bilayer of the vesicle.
With the concentration of peptide utilized (10 ,M), the
amount of peptide depleted from the surrounding solution
would occupy a shell volume -20 ,um thick around the
vesicle. Utilizing the Stokes-Einstein relation to estimate
diffusion coefficient of a wt-20 peptide of radius 10 A and
an outer bound on the depletion layer of 20,um thick around
the vesicle, the flux of peptide to the bilayer surface (-6 X
1012 molecules/(cm2 s)) is more than 10% of the range of
insertion rates observed here for 10 ,M wt-20 at pH 5. The
actual depletion layer would probably be much less than 20
,tm-particularly when the vesicle is initially exposed to
wt-20 and very little peptide has inserted into the bilayer.
Because the flux can be approximated as being inversely
proportional to the depletion layer thickness, a smaller de-
pletion layer will yield a higher flux. These estimations
10 ,M pH 5 wt-20) may be diffusion limited. If the peptide
is inserted only in the outer bilayer and the inner bilayer is
stretched, the amount of peptide inserted can be estimated at
-3 X 108 wt-20 for a £A/AO of -0.1.
An important finding of the present study is the complete
lack of area expansion of the bilayer in the presence of a
mutant of wt-20 in which the N-terminal glycine is absent.
This lAGI peptide shows an area expansion plot at both pH
5.0 and pH 7.0 similar to those of peptide-absent controls.
This result corresponds with the inability of this peptide to
hemolyse red blood cells, shown by Wharton et al. (1988),
and the lack of fusion activity of cells expressing HA with
cleaved N-terminal glycine (Steinhauer et al., 1995). Our
results with GIG1 suggest that this peptide does not embed in
the membrane bilayer. We reach this conclusion because of
the lack of area expansion that occurs when this peptide is
introduced to the bilayer in comparison to the wt-20 peptide
and other amphiphiles that insert into the bilayer previously
studied by micropipette aspiration (Simon et al., 1994;
Needham and Zhelev, 1995). In contrast to the work pre-
sented here, tryptophan fluorescence studies by Wharton et
al. (1988) and Gray et al. (1996) showed that a significant
blue shift occurred when AGI was placed with phosphati-
dylcholine vesicles at pH 7 and even more pronounced at
pH 5, indicating that the tryptophans were sampling a hy-
drophobic environment. It is possible that the experimental
conditions were different enough in our experiments to
preclude the association of AGI with lipid membranes. A
particularly significant difference is the use of small unila-
mellar vesicles in previous tryptophan fluorescence studies
(Gray et al., 1996; Wharton et al., 1988) and the use of
much larger (20-30 ,um) low tension (below the stretching
dominated regime; Evans and Rawicz, 1990), minimal cur-
vature vesicles used in this study. It is possible that the
larger, stress-free vesicles used in this study more closely
resemble the cell membrane. Thus, like the hemolytic stud-
ies, we do not see any perturbation of the membrane with
the use of AG1. It is also possible that AGI can adsorb to the
membrane, but does not intercalate. In support of this pos-
sibility, Gray et al. (1996) have shown that AGI interacts
more strongly with lipid headgroups in comparison to the
wild-type peptide. However, we have been unsuccessful in
using preexposure of vesicles to AGI peptide as a means of
blocking wt-20 binding (data not shown).
In the case of wt-20, we do see a large change in the area
expansion rate and maximum area expansion as the pH is
lowered, and this is in agreement with the tryptophan fluo-
rescence data of Wharton et al. (1988). In their work, there
was a more significant blue shift of the tryptophan fluores-
cence for wt-20 in the presence of vesicles of phosphatidyl-
choline at a pH of 5 in comparison to a pH of 7.
In similar work studying the adsorption of lysophosphati-
dylcholine (lysoPC) into the bilayer, using micropipette
aspiration, it was shown that lysoPC adsorbs and interca-
lates rapidly into the outer monolayer, with a slower rate of
flip-flop to the inner monolayer of the bilayer (Needham
indicate that the faster insertion rates observed here (e.g., for
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and Zhelev, 1995). If this were the case here, the area
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expansion observed would be almost entirely the result of
an increased mass of the outer monolayer. If the wt-20
peptides adsorb much more rapidly to the outer monolayer,
then redistribution (flip-flop) processes occur, bending
stresses will certainly be significant, as a bilayer can only be
stretched by -5% before mechanical failure occurs (Evans
and Needham, 1987). Bending stress of the outer monolayer
may be relieved by the formation of nanometer-scale pores
and the rapid flip-flop of phospholipid or peptide from the
outer monolayer to the inner monolayer (Fattal et al., 1994).
This interpretation of the mechanism of wt-20 fusion pep-
tide membrane disruption at low pH is supported by our
data, showing that when exposure to the fusion peptide
wt-20 resulted in less than -5% area expansion, we observe
an area expansion plateau and transient membrane stability
(pH 7.0 and pH 6.0).
An intriguing question is: Why does the membrane be-
come porous (at long times), even when the amount of area
expansion is small and has leveled off? It is possible that a
combination of factors may be required for the formation of
porous defects when the membrane area has expanded
slowly. Possibly, a quantity of the active conformation of
the peptide must be present (the peptide may settle into a
more active form with time), or a period of time may be
required for a peptide to aggregate (self-associate) in the
membrane, causing local perturbations. Another interesting
question is: Why can the membrane area be expanded by as
much as 11% and why does that appear to be the maximum
area expansion possible. Perhaps, for short periods of time,
the membrane can be expanded more than the critical 5% in
which a bilayer fails. It may take time for the membrane to
become porous and for flip-flop processes to occur. We may
also ask: Do the densities of peptides inserted into the
bilayers here compare with the densities of hemagglutinin
spike proteins on a virion surface? The intact virion surface
is covered with approximately one hemagglutinin protein
per 80 nm2 (Burger et al., 1991). Therefore, presumably, the
virion could insert approximately three HA fusion peptides
into the target membrane per 80 nm2 over a small area of
contact (each HA protein contains three fusion peptides).
The largest vesicle area expansion measured here would
correspond to an unrealistically high HA fusion peptide
coverage of one peptide per 3 nm2 (assuming 30 A2/wt-20
as a lower bound). However, area expansions of AA/AO =
0.01 (pH 7, 10 ,M wt-20) compare more closely to the
virion surface coverage. Even at these low area coverages,
porous defects are formed, although over a longer time.
Our observations here help explain our earlier work (Solt-
esz and Hammer, 1995) and that of Wharton et al. (1988),
Duzgune, and Shavnin (1992), Duzgune, and Gambale
(1988), and Rafalski et al. (1991), who observed that expo-
sure of vesicles or cells to micromolar amounts of wild-type
hemagglutinin fusion peptides at low pH resulted in leakage
of contents. Above all, it has been shown that the interaction
of fusion peptides with a vesicle membrane is a dynamic
process; the concentration and barrier properties of a mem-
brane bilayer can be changed in seconds by exposure to the
hemagglutinin fusion peptide of influenza virus. These re-
sults also suggest that kinetic studies of properties such as
peptide conformation and lipid-peptide interaction may be
as critical to discerning the complete mechanism of lipid
disruption as studies in which measurements are taken at
much larger time scales than the area expansion processes
seen in these experiments.
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